Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial.

Literature DB >> 29309496

Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial.

Babak B Navi^1,2,3, Randolph S Marshall⁴, Dylan Bobrow³, Samuel Singer³, Jacqueline B Stone³, Maria T DeSancho⁵, Lisa M DeAngelis^1,2,3.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2018 PMID： 29309496 PMCID： PMC5885855 DOI： 10.1001/jamaneurol.2017.4211

Source DB: PubMed Journal: JAMA Neurol ISSN： 2168-6149 Impact factor: 18.302

× No keyword cloud information.

6 in total

1. Recurrent thromboembolic events after ischemic stroke in patients with cancer.

Authors: Babak B Navi; Samuel Singer; Alexander E Merkler; Natalie T Cheng; Jacqueline B Stone; Hooman Kamel; Costantino Iadecola; Mitchell S V Elkind; Lisa M DeAngelis
Journal: Neurology Date: 2014-05-21 Impact factor: 9.910

Review 2. Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis.

Authors: Maria Cristina Vedovati; Federico Germini; Giancarlo Agnelli; Cecilia Becattini
Journal: Chest Date: 2015-02 Impact factor: 9.410

3. Screen failure data in clinical trials: Are screening logs worth it?

Authors: Jordan J Elm; Yuko Palesch; J Donald Easton; Anne Lindblad; William Barsan; Robert Silbergleit; Robin Conwit; Catherine Dillon; Mary Farrant; Holly Battenhouse; Aaron Perlmutter; S Claiborne Johnston
Journal: Clin Trials Date: 2014-06-12 Impact factor: 2.486

4. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

Authors: Marc I Chimowitz; Michael J Lynn; Harriet Howlett-Smith; Barney J Stern; Vicki S Hertzberg; Michael R Frankel; Steven R Levine; Seemant Chaturvedi; Scott E Kasner; Curtis G Benesch; Cathy A Sila; Tudor G Jovin; Jose G Romano
Journal: N Engl J Med Date: 2005-03-31 Impact factor: 91.245

5. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology.

Authors: Christopher J Schwarzbach; Anke Schaefer; Anne Ebert; Valentin Held; Manuel Bolognese; Micha Kablau; Michael G Hennerici; Marc Fatar
Journal: Stroke Date: 2012-09-20 Impact factor: 7.914

6. Association between incident cancer and subsequent stroke.

Authors: Babak B Navi; Anne S Reiner; Hooman Kamel; Costantino Iadecola; Mitchell S V Elkind; Katherine S Panageas; Lisa M DeAngelis
Journal: Ann Neurol Date: 2015-01-07 Impact factor: 10.422

6 in total

15 in total

Review 1. [Rare causes of stroke-a frequent stroke etiology].

Authors: Antje Schmidt-Pogoda; Jens Minnerup
Journal: Nervenarzt Date: 2019-10 Impact factor: 1.214

Review 2. Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel.

Authors: Victor J Del Brutto; Seemant Chaturvedi; Hans-Christoph Diener; Jose G Romano; Ralph L Sacco
Journal: J Am Coll Cardiol Date: 2019-08-13 Impact factor: 24.094

Enoxaparin vs Aspirin in Patients With Cancer and Ischemic Stroke: The TEACH Pilot Randomized Clinical Trial.

1. Recurrent thromboembolic events after ischemic stroke in patients with cancer.

Review 2. Direct oral anticoagulants in patients with VTE and cancer: a systematic review and meta-analysis.

3. Screen failure data in clinical trials: Are screening logs worth it?

4. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.

5. Stroke and cancer: the importance of cancer-associated hypercoagulation as a possible stroke etiology.

6. Association between incident cancer and subsequent stroke.

Review 1. [Rare causes of stroke-a frequent stroke etiology].

Review 2. Antithrombotic Therapy to Prevent Recurrent Strokes in Ischemic Cerebrovascular Disease: JACC Scientific Expert Panel.

3. Chronic Lymphocytic Leukemia Resulting in Hemorrhagic Brain Masses After Sepsis.

Review 4. Ischemic stroke in cancer patients: A review of an underappreciated pathology.

5. Three Territory Sign: An MRI marker of malignancy-related ischemic stroke (Trousseau syndrome).

Review 6. Cancer and Embolic Stroke of Undetermined Source.

7. Suitability of Thrombolysis for Patients With Acute Ischemic Stroke Complicated With Trousseau Syndrome.

8. Stroke in malignancy: complexities of diagnosis and management: a case report.

Review 9. Pathophysiologic and Therapeutic Perspectives Based on Thrombus Histology in Stroke.

Review 10. Ischemic Stroke Risk Among Adult Brain Tumor Survivors: Evidence to Guide Practice.